drugset / Trial / NCT01614912
Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The study evaluates the long term safety and efficacy of SM-13496 in patients with schizophrenia.
Timeline
- Start
- 2012-08
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 40 mg | Oral |
| Subject | Lurasidone | Small molecule | 80 mg | Oral |